How Much Did Micromed Raise?
Funding & Key Investors

Micromed, a company specializing in neurophysiology diagnostic solutions, has secured $150K in total funding, with its most recent capital infusion amounting to $150K. This recent major strategic investment underscores the company's established position in the market and its ongoing trajectory for growth and development in the medical technology sector.

What is Micromed?

Micromed
ManufacturingMedical Devices & Equipment

Founded in 1982 by Claudio Perissinotto and Dr. Cipriano Castellaro, Micromed has a rich history of innovation in the diagnostic EEG space. The company is recognized for pioneering advancements such as the first 2-channel ambulatory EEG recorder, which later evolved into a 12-channel version, and the industry's first true 24-channel digital EEG system. Acquired by Archimed, a healthcare-focused investment firm, in 2016, Micromed has since expanded its global presence to 78 markets and employs over 100 individuals. The company emphasizes a partnership approach with its customers, fostering close relationships between its R&D team and users to ensure rapid delivery of customer-driven solutions. Their philosophy centers on earning trust through quality products, service, and support, aiming to empower medical professionals in improving patient care.

How much funding has Micromed raised?

Micromed has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in Micromed

PPP

Public-Private Partnership

Archimed

Archimed is a private equity firm specializing in the healthcare industry, known for its strategic investments in companies poised for growth and international expansion.

Undisclosed investor

Undisclosed investor participating in the funding round, indicating potential strategic alignment or a desire for privacy in their investment activities.

What's next for Micromed?

With a history of significant technological contributions and a recent strategic investment, Micromed is well-positioned for continued expansion and innovation. The company's late-stage funding context suggests a focus on scaling operations, enhancing its international footprint, and potentially developing next-generation neurophysiology diagnostic tools. Micromed's established relationships with customers and distributors, coupled with its agile R&D process, will likely enable it to capitalize on market opportunities and further solidify its leadership in the diagnostic EEG field.

See full Micromed company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingTextiles & Apparel
Food & BeverageManufacturingRetailGrocery Retail
Industrial Machinery & EquipmentManufacturingRetailOther Rental Stores (Furniture, A/V, Construction & Industrial Equipment)
ManufacturingPharmaceuticalsBusiness ServicesResearch & Development

Frequently Asked Questions Regarding Micromed Financial Insights

What are the most recent funding rounds that Micromed has completed, and what were the funding rounds?
Micromed has recently completed 1 funding rounds: Debt on Apr 29, 2020.
What is the total amount of funding Micromed has raised to date?
Micromed has raised a total of $150K in funding to date.
How many funding rounds has Micromed completed?
Micromed has completed 1 funding rounds.
How much funding did Micromed raise in its most recent funding round?
Micromed raised $150K in its most recent funding round.
Who are the lead investors in Micromed's latest funding round?
The lead investor in Micromed's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Micromed's history?
The largest funding round in Micromed's history was $150K.
See more information about Micromed